Advances in vein graft intervention

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Interventional Cardiology

• Publication date

  2010-11-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/ICA.10.66
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion

  2010cited by this paper
• Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.

  2010cited by this paper
• Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial.

  2010cited by this paper
• Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions.

  2010cited by this paper
• The Graft Imaging to Improve Patency (GRIIP) clinical trial results.

  2010cited by this paper
• Drug-eluting stents in saphenous vein graft interventions: a systematic review.

  2010cited by this paper
• Paclitaxel-Eluting Stents for Chronically Occluded Saphenous Vein Grafts (EOS) Study.

  2010cited by this paper
• Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.

  2010cited by this paper
• Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis.

  2010cited by this paper
• Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room.

  2009cited by this paper
• Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.

  2009cited by this paper
• Comparison of Plaque Sealing With Paclitaxel-Eluting Stents Versus Medical Therapy for the Treatment of Moderate Nonsignificant Saphenous Vein Graft Lesions: The Moderate VEin Graft LEsion Stenting With the Taxus Stent and Intravascular Ultrasound (VELETI) Pilot Trial

  2009cited by this paper
• Comparación de los stents liberadores de fármaco y los convencionales en puentes de safena. Resultados inmediatos y a largo plazo

  2009cited by this paper
• Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions.

  2009cited by this paper
• [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].

  2009cited by this paper
• On-pump versus off-pump coronary-artery bypass surgery.

  2009cited by this paper
• Embolic protection during saphenous vein graft interventions.

  2009cited by this paper
• A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.

  2009cited by this paper
• A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.

  2008cited by this paper
• Long‐term clinical outcomes of real‐world experience using sirolimus‐eluting stents in saphenous vein graft disease

  2008cited by this paper
• Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).

  2008cited by this paper
• Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions

  2008cited by this paper
• Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions

  2008cited by this paper
• Late outcomes of drug‐eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis

  2008cited by this paper
• Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts.

  2008cited by this paper
• Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.

  2008cited by this paper
• Percutaneous intervention on the saphenous vein bypass grafts—Long‐term outcomes

  2008cited by this paper
• Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.

  2008cited by this paper
• Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients

  2008cited by this paper
• Lack of clinical long‐term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts

  2008cited by this paper
• Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions.

  2008cited by this paper
• Comparison of the slow-release polymerbased paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions

  2007cited by this paper
• Chronic total occlusion treatment in post‐CABG patients: Saphenous vein graft versus native vessel recanalization—Long‐term follow‐up in the drug‐eluting stent era

  2007cited by this paper
• The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.

  2007cited by this paper
• "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention.

  2007cited by this paper
• Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

  2007cited by this paper
• Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.

  2007cited by this paper
• Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.

  2007cited by this paper
• Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.

  2007cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cited by this paper
• Embolic Protection Devices in Aortocoronary Saphenous Vein Graft Intervention

  2006cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cited by this paper
• Efficacy of intracoronary nicardipine in the treatment of no‐reflow during percutaneous coronary intervention

  2006cited by this paper
• Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study

  2006cited by this paper
• Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts.

  2006cited by this paper
• Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial.

  2006cited by this paper
• Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.

  2006cited by this paper
• Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.

  2006cited by this paper
• Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.

  2006cited by this paper
• Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.

  2005cited by this paper
• Release and elimination of soluble vasoactive factors during percutaneous coronary intervention of saphenous vein grafts: analysis using the PercuSurge GuardWire distal protection device.

  2005cited by this paper
• Drug‐eluting stenting is superior to bare metal stenting in saphenous vein grafts

  2005cited by this paper
• Prognostic significance of nonsustained ventricular tachycardia during dobutamine stress echocardiography.

  2005cited by this paper
• Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease.

  2005cited by this paper
• Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

  2005cited by this paper
• A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial.

  2005cited by this paper
• Comparison of saphenous vein and internal thoracic artery graft patency by coronary system.

  2005cited by this paper
• Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.

  2005cited by this paper
• Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.

  2005cited by this paper
• Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.

  2005cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.

  2004cited by this paper
• Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no‐reflow phenomenon

  2004cited by this paper
• Saphenous vein graft disease.

  2004cited by this paper
• Treatment of Saphenous Vein Bypass Grafts With Ultrasound Thrombolysis: A Randomized Study (ATLAS)

  2003cited by this paper
• Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries.

  2003cited by this paper
• Percutaneous treatment of saphenous vein graft disease: the ongoing challenge.

  2003cited by this paper
• Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study

  2003cited by this paper
• Current Management Of Saphenous Vein Graft Disease

  2003cited by this paper
• Interventional cardiology: abstractRandomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the randomized evaluation of polytetrafluoroethylene COVERed stent in saphenous vein grafts (RECOVERS) trial☆

  2003cited by this paper
• Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts

  2003cited by this paper
• No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.

  2003cited by this paper
• Society of cardiac angiography and interventions: Suggested management of the no‐reflow phenomenon in the cardiac catheterization laboratory

  2003cited by this paper
• A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.

  2003cited by this paper
• Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts

  2002cited by this paper
• Thoughts on the role of the healing professions and the events of September 11, 2001.

  2002cited by this paper
• Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts.

  2002cited by this paper
• Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials

  2002cited by this paper
• Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy.

  2002cited by this paper
• Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.

  2002cited by this paper
• Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients.

  2002cited by this paper
• Aspirin and mortality from coronary bypass surgery.

  2002cited by this paper
• A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).

  2002cited by this paper
• Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.

  2001cited by this paper
• Percutaneous intervention in saphenous venous grafts: in-stent restenosis lesions are safer than de novo lesions.

  2001cited by this paper
• Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting.

  2001cited by this paper
• Clinical and Angiographic Effects of Chronic Calcium Channel Blocker Therapy Continued Beyond First Postoperative Year in Patients With Radial Artery Grafts: Results of a Prospective Randomized Investigation

  2001cited by this paper
• Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.

  2001cited by this paper
• Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts.

  2001cited by this paper
• Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.

  2001cited by this paper
• Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results.

  2001cited by this paper
• Restenosis in Saphenous Vein Grafts.

  2001cited by this paper
• Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

  2000cited by this paper
• Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents.

  2000cited by this paper
• Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow‐no reflow phenomenon

  2000cited by this paper
• Treatment of Aortocoronary Vein Graft Lesions With Membrane-Covered Stents: A Multicenter Surveillance Trial

  2000cited by this paper
• Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes.

  2000cited by this paper
• Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.

  2000cited by this paper
• Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system.

  1999cited by this paper
• Retrieval and analysis of particulate debris after saphenous vein graft intervention.

  1999cited by this paper

• Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility?

  2021cites this paper
• Love in Vain?

  2018cites this paper
• Improving outcomes in cardiovascular practice

  2010cites this paper
• The advent of new antiplatelets therapies with prasugrel and ticagrelor has warranted the review of antiplatelets therapies for percutaneous coronary intervention for myocardial infarction.

  2010cites this paper